Skip to content
FIND A HEALTH VALLEY ACTOR
BIND 2025  - Investors

When

1 April 2025    
8 h 30 min - 20 h 00 min
CHF0.00
Purchase your tickets

Get your free investor ticket for the BIND 2025, on 1 April 2025 at Campus Biotech Geneva

 

We are thrilled to invite you to the BIND 2025 – BioInnovation Day 🧬, that will take place on 1 April 2025, at Campus Biotech Geneva. This event will showcase 30 exceptional life sciences projects from the most prestigious academic institutions in Western Switzerland, selected for their high potential in key fields such as Medtech, Biotech, Pharma, Digital Health, Biotools, Foodtech, etc.

 

Why Attend?
As an investor, you will have the opportunity to:

  • Discover early-stage life sciences projects with high growth potential.
  • Engage directly with project leaders and their academic mentors.
  • Forge strategic partnerships with innovators and industry leaders.

 

Key Information

 

📅 Date: April 1, 2025 | Time: 9:00 AM to 6:00 PM
📍 Location: Campus Biotech Geneva
🙋🏻‍♂️ Participants: 150–200 attendees
🔬 Projects presented: 30 promising early-stage innovations in medtech, biotech, digital health, biotools, and more.
🏛 Academic partners: UNIGE, HUG, UNIL, CHUV, EPFL, UNINE, UNIFR, HES-SO Valais Wallis, HEIG-VD, and more.

 

PROGRAMME

  • 8.30 am – 8.55 am | BADGE COLLECTION
  • 9 am | WELCOME ADDRESS
    • Delphine BACHMANN, Geneva State Councillor for Economic Affairs
    • Prof. Antoine GEISSBUHLER, BioAlps’ President, Dean of Geneva University of Medicine
    • Antonio GAMBARDELLA, FONGIT’s Director
  • 9.15 am – 10 am | PROJECT PITCHES 
  • 10 am – 10.30 am | BREAK
  • 10.30 am – 11.15 am | ROUND-TABLE: Building Synergies Between Life Sciences Startups and Industry
    • Naja NYFFENEGGER, Senior Manager Research Innovation Europe CSL R&D, Vifor Pharma
    • Dr Julien DOUET, Head of Cell Line Technologies, Merck Group
    • Dr Fabrice PARADIES, Director Industrial Business Development & Global Commercial Alliances, Debiopharm Research
    • Pr Yogeshvar KALIA, Full Professor, School of Pharmaceutical Sciences, UNIGE – Moderator
  • 11.15 am – 12.00 pm | PROJECT PITCHES 
  • 12.00 pm – 1.30 pm | LUNCH
  • 1.30 pm | WELCOME AFTERNOON – L&S
  • 1.40 pm – 2.15 pm | PROJECT PITCHES 
  • 2.15 pm – 3 pm | Session : Investments in Life Sciences
    • Caroline GUEISSAZ – Startup Advisor & Management Consultant, Honorary member of Business Angel Switzerland 
    • Steffen EHRHARDT – Head of SICTIC Operation Team 
    • Olivier VAURY – Deeptech Investor & Advisor
  • 3 pm – 3.30 pm | BREAK
  • 3.30 pm – 4.15 pm | PROJECT PITCHES + Introduction CSEM
  • 4.15 pm – 4.35 pm | KEYNOTE: Patrick GRISS – co-founder & CEO, Zühlke Ventures, author of Deep Tech Playbook
  • 4.40 pm | AWARD CEREMONY
  • 4.50 pm | NETWORKING COCKTAIL

SPONSORS

Gold: Lenz&Staehelin | Silver: IGE IPI | Bronze: CSEM, EPFL TTO, Innovaud, Intuitive Ventures, Katzarov SA, Reuteler & Cie, Wyss Center for Bio and Neuroengineering

 

PARTNER

FONGIT

 

ORGANISERS

UnitecPACTTBioAlps AssociationState of Geneva

 

 

ACADEMIC INSTITUTIONS

CHUV, CSEM, EPFL, UNIL, UNIGE, HUGUNIFR, UNINE, HEPIA, HES-SO Valais WallisWyss Center, will be presenting their latest life sciences projects, ready to become startups or to be licensed.

 

If you have any questions, please write to contact@bioalps.org.

Registration

Ticket Registration

Booking Information

Business Angel
Corporate VC
Fondation & Family VC
Institutional VC
Public & Philantropic VC
Venture Capital
Other

Biotech
Bio Tools
Digital Health
Medtech
Pharma
Other

Agtech
Cleantech
Edtech
Foodtech
Fintech
IT
Media & Entertainment
Trust

Level 1 - Basic principles observed
Level 2 - Technology concept formulated
Level 3 - Experimental proof of concept
Level 4 - Technology validated in lab
Level 5 - Technology validated in labTechnology validated in relevant environment
Level 6 - Technology demonstrated in relevant environment
Level 7 - System prototype demonstration in operational environment
Level 8 - System complete and qualified
Level 9 - Actual system proven in operational environment

Up to CHF 100k
Up to CHF 500k
Up to CHF 1 M
Over CHF 1M

Booking Summary

1
x BIND 2025 : Investor Ticket
CHF0.00
Total Price
CHF0.00